Biotest AG (XTER:BIO)
€ 41 0 (0%) Market Cap: 1.34 Bil Enterprise Value: 1.83 Bil PE Ratio: 7.95 PB Ratio: 3.07 GF Score: 68/100

Q4 2022 Biotest AG Earnings Call Transcript

Mar 23, 2023 / 10:00AM GMT
Release Date Price: €42.9 (-0.46%)
Monika Buttkereit
Biotest Aktiengesellschaft - Head of IR

Good morning, ladies and gentlemen. It's a pleasure to have you here today in Dreieich for our first hybrid meeting of the analyst conference. So welcome here in Dreieich, and welcome also the team's participants, they are here today from Germany, Spain, U.K. and the United States, so welcome. Today, it will be Michael Ramroth, CEO, to give an update on the ongoing business and a research and development update; and Ainhoa Zubiag,a, CFO of Biotest to give you an update on the plasma environment and also on the financials. With this, I'd like to hand over to Michael.

Michael Ramroth
Biotest Aktiengesellschaft - Chairman of the Management Board & CEO

Yes. Thank you very much, and a warm welcome also from my side, especially to the early birds in the United States. So great that you are following us today. And you know all the long-term followers of you and some of you have been following Biotest since decades almost. You know that we always start with highlights, a summary of our presentation. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot